LOSS OF BONE MASS IN WOMEN WITH ANOREXIA-NERVOSA ON TUBE-FEEDING, AND ITS PREVENTION BY BISPHOSPHONATES

被引:0
|
作者
KOPP, HG
RUEGSEGGER, P
DAMBACHER, MA
机构
[1] UNIV ZURICH,INST BIOMED TECH,CH-8006 ZURICH,SWITZERLAND
[2] SWISS FED INST TECHNOL,CH-8092 ZURICH,SWITZERLAND
[3] UNIV BALGRIST,ORTHOPAD KLIN,CALCIUMSTOFFWECHSEL FORSCHUNGSLAB,BALGRIST,SWITZERLAND
[4] DEPT INNERE MED,ZURICH,SWITZERLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Women with long-lasting anorexia nervosa often display osteopenia. Furthermore, we have observed additional marked loss of bone mass under tube feeding in underweight anorexia patients. Such loss of bone substances can lead to spontaneous fractures. Therefore, we investigated in this study whether this undesirable effect of tube-feeding might be prevented by administration of bisphosphonates (Didronel(R)), a substance that inhibits the activity of osteoclasts. Bone density was assessed by a high-precision, low dose, quantitative computed tomography of the distal radius and the distal tibia. A group of 6 anorexia patients (tube feeding with an initial underweight of 74.9 +/- 10.3% of ideal weight, mean +/- SD) treated with bisphosphonates showed only slight loss of trabecular bone (0.8 +/- 0.2%, mean +/- SEM) after 2 months of observation, whereas in 2 control groups a marked diminution of trabecular bone was observed (4.4 +/- 0.7% and 7.6 +/- 1.1% respectively, p < 0.001 for each comparison). Cortical bone was unchanged throughout. Treatment with bisphosphonates provides effective prevention of bone loss observed in tube-feeding.
引用
收藏
页码:538 / 543
页数:6
相关论文
共 49 条
  • [41] Role of Sclerostin and Dickkopf-1 in the Dramatic Alteration in Bone Mass Acquisition in Adolescents and Young Women With Recent Anorexia Nervosa
    Maimoun, Laurent
    Guillaume, Sebastien
    Lefebvre, Patrick
    Philibert, Pascal
    Bertet, Helena
    Picot, Marie-Christine
    Gaspari, Laura
    Paris, Francoise
    Courtet, Philippe
    Thomas, Eric
    Mariano-Goulart, Denis
    Bringer, Jacques
    Renard, Eric
    Sultan, Charles
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (04): : E582 - E590
  • [42] Efects of the low body mass index on the vertebral mineral density and bone turnover in women with mild form of anorexia nervosa and regular menses
    Dumitrache, C
    Grigorie, D
    Barbu, C
    Neacsu, E
    Dumitrache, M
    BONE, 2001, 28 (05) : S186 - S186
  • [43] FLURBIPROFEN IN THE PREVENTION OF BONE MASS-LOSS IN IMMEDIATELY POSTMENOPAUSAL WOMEN - A PILOT-STUDY
    CHESNUT, C
    MURANO, R
    DEBROCK, J
    PITZEL, P
    ROGERS, M
    RENCKEN, M
    LAI, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S319 - S319
  • [44] ORAL PROGESTOGEN-ONLY CONTRACEPTION MAY PROTECT AGAINST LOSS OF BONE MASS IN BREAST-FEEDING WOMEN
    CAIRD, LE
    REIDTHOMAS, V
    HANNAN, WJ
    GOW, S
    GLASIER, AF
    CLINICAL ENDOCRINOLOGY, 1994, 41 (06) : 739 - 745
  • [45] Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial (vol 114, pg 999, 2009)
    McClung, M.
    Miller, P.
    Recknor, C.
    Messenbrink, P.
    Bucci-Rechtweg, C.
    Benhamou, C. -L.
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (06): : 1308 - 1308
  • [46] Bone mass, free 25(OH) vitamin D, oxidized and non-oxidized PTH in young women 3 years after intensive nutrition therapy for severe anorexia nervosa
    Svedlund, Anna
    Tubic, Bojan
    Elfvin, Anders
    Swolin-Eide, Diana
    Pettersson, Cecilia
    Ellegard, Lars
    Magnusson, Per
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 356 - 356
  • [47] The efficacy of two dosing regimens (daily colecalciferol versus cyclical calcidiol) for the prevention of bone mass loss in postmenopausal women with vitamin D insufficiency
    Cobo, T
    Aguado, P
    González, M
    Bonilla, G
    Martinez, M
    Mola, EM
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 454 - 454
  • [48] The efficacy of two dosing regimens (daily colecalciferol versus cyclical calcidiol) for the prevention of bone mass loss in postmenopausal women with Vitamin D insufficiency.
    Aguado, P.
    González-Casaús, M. L.
    Cobo, T.
    del Campo, T.
    Martínez, M. E.
    Martin-Mola, E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S306 - S306
  • [49] Higher perimenopausal bone mass and reduced postmenopausal bone loss in women carrying the C161T SNP in the PPAR gamma gene. The Danish osteporosis prevention study
    Tofteng, C. L.
    Petersen, S.
    Teilmann, J.
    Eiken, P.
    Abrahamsen, B.
    Langdahl, B. L.
    Jensen, J. B.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S25 - S25